Two Proposed Early Biomarker Tests of ASD: More Harm Than Good
- 01-04-2014
- Letter to the Editor
Gepubliceerd in:
- Auteurs
- George M. Anderson
- Sherin S. Stahl
- Gepubliceerd in
- Journal of Autism and Developmental Disorders | Uitgave 4/2014
Extract
We have serious concerns regarding two recent highly publicized papers proposing early biomarker tests for autism or autism spectrum disorder (ASD) (Braunschweig et al. 2013, Walker et al. 2013). The paper of Braunschweig et al. concerns patterns of anti-brain antibodies detected in maternal plasma, while Walker et al. report on the occurrence of a microscopic morphological abnormality (the trophoblast inclusion) in placental tissue. Both groups suggest that their measure should be used clinically to test for autism/ASD risk and to influence early intervention, and websites promoting the tests have been established (pediatricbioscience.com; medicine.yale.edu/obgyn/kliman/autism/asd/index.aspx). …
- Titel
- Two Proposed Early Biomarker Tests of ASD: More Harm Than Good
- Auteurs
-
George M. Anderson
Sherin S. Stahl
- Publicatiedatum
- 01-04-2014
- Uitgeverij
- Springer US
- Gepubliceerd in
-
Journal of Autism and Developmental Disorders / Uitgave 4/2014
Print ISSN: 0162-3257
Elektronisch ISSN: 1573-3432 - DOI
- https://doi.org/10.1007/s10803-013-1981-x
Deze inhoud is alleen zichtbaar als je bent ingelogd en de juiste rechten hebt.